Press Release Details

Quest Diagnostics Names James D. Chambers Marketing & Business Development Leader


TETERBORO, N.J., February 20, 1998 –James D. Chambers has been appointed Senior Vice President, Marketing and Business Development, at Quest Diagnostics Incorporated (NYSE: DGX), reporting to Kenneth W. Freeman, Chairman and Chief Executive Officer.

In this role, Mr. Chambers will be responsible for growth markets, with an emphasis on large buyers of health care services, including hospital networks, managed care companies and group purchasing organizations. In addition, he will oversee marketing, with particular emphasis on identifying and pursuing emerging growth opportunities. He succeeds Don M. Hardison Jr., who will be leaving the company to pursue other interests.

"Jim's breadth of experience, energy and strong leadership will provide the spark needed to successfully implement our business strategy to become the preferred partner with large buyers," said Mr. Freeman.

Mr. Chambers, 41, previously served as Vice President, Administration, with responsibility for Investor Relations and Communications. Kenneth R. Finnegan, Vice President, Treasurer, will assume additional responsibility for Investor Relations. Kurt R. Fischer, Vice President, Human Resources, will assume additional responsibility for overseeing Corporate Communications.

Mr. Chambers joined the company in 1993 as Treasurer, and has also served as Chief Financial Officer and Vice President, Billing and Investor Relations. Since 1986, he served in a variety of executive positions at Corning Incorporated, from which Quest Diagnostics was spun off at the end of 1996. He graduated from Dickinson College with a B.A. in 1978, received his MBA from Southern Methodist University in 1980, and a Master's Degree in International Management from the American Graduate School of International Management in 1980.

Quest Diagnostics Incorporated is one of the nation's leading providers of diagnostic testing, information and services with laboratories across the United States. The wide variety of tests performed on human tissue and fluids helps doctors and hospitals diagnose, treat and monitor disease. Its Nichols Institute unit conducts research, specializes in esoteric testing using genetic screening and other advanced technologies, performs clinical studies testing, and manufactures and distributes diagnostic test kits and instruments. Quest Informatics collects and analyzes laboratory, pharmaceutical and other data to help large healthcare customers identify and monitor patients who are at-risk for certain diseases and to use clinical data for other related business activities. Additional company information can be found on the Internet at: